CD33 and hepatic veno-occlusive disease: CD33 is also expressed on Kupffer cells, and severe hepatic toxicity, including veno-occlusive disease, has been reported with CD33-targeting antibody-drug conjugates, but this toxicity was attributed to the calicheamicin component rather than the targeting of Kupffer cells [55].